Abstract:Acute myeloid leukemia (AML) remains highly fatal, highlighting the need for improved understanding of signal pathways that can lead to the development of new therapeutic regimens targeting common molecular pathways shared across different AML subtypes. Here we demonstrate that astrocyte elevated gene-1 (AEG-1) is one of such pathways, involving in cell cycle and apoptosis regulation and contributing to enhanced proliferation and chemoresistance in HL-60 and U937 AML cells. The pleiotropic effects of AEG-1 on AML were found to correlate with two novel target genes, Aurora kinase A (AURKA) and Akt1. Down-regulation of AEG-1 by short-hairpin RNA (shRNA) could not only decrease AURKA expression both on mRNA and protein levels but also decrease the levels of pAkt473 and pAkt308 (the active forms of phosphorylated Akt), similar effect as using AURKA inhibitor Tozasertib (VX680). Furthermore, the AEG-1 shRNA-induced malignant phenotype changes could be mitigated by forced overexpression of AURKA through increased Akt1 activation and phosphorylation in AML cells. On the other hand, although exogenous expression of AEG-1 could increase both AURKA and Akt expression levels the simultaneous use of AURKA inhibitor Tozasertib blocked AEG-1's role of up-regulation of Akt expression in ECV304 cells, suggesting that AURKA might be a key mediator of AEG-1 in regulating Akt activation, and a key effector of AEG-1 in maintaining the malignant state of AML. Moreover, knockdown AEG-1 expression also changed the expression levels of PTEN, survivin and stathmin, the genes that have been reported to be involved in the development of several other malignant tumors. Our results provide evidence for AEG-1's carcinogenesis role in AML and reveal a novel functional link between AEG-1 and AURKA on Akt1 activation. AEG-1 can be an important candidate as a drug design target within AURKA signal pathway for more specific killing of AML cells while sparing normal cells.

Aurora-A down-regulates IkappaBα via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival

Aurora-A, A Negative Prognostic Marker, Increases Migration and Decreases Radiosensitivity in Cancer Cells

Aurora Kinase Inhibitory VX-680 Increases Bax/Bcl-2 Ratio and Induces Apoptosis in Aurora-A-high Acute Myeloid Leukemia.

Aurora A Is Essential for Early Embryonic Development and Tumor Suppression

The Mitotic Kinase Aurora-A Induces Mammary Cell Migration And Breast Cancer Metastasis By Activating The Cofilin-F-Actin Pathway

Aurora Kinase Inhibition Induces PUMA Via NF-κB to Kill Colon Cancer Cells.

Aurora‐A Kinase: A Potent Oncogene and Target for Cancer Therapy

Aurora kinase small molecule inhibitor destroys mitotic spindle, suppresses cell growth, and induces apoptosis in oral squamous cancer cells.

Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells.

Cancer Biology and Signal Transduction Aurora Kinase Inhibition Induces PUMA via NFk B to Kill Colon Cancer Cells

AEG-1 Overexpression is Essential for Maintenance of Malignant State in Human AML Cells Via Up-Regulation of Akt1 Mediated by AURKA Activation.

Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression

Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway.

Inhibition of Aurora A Promotes Chemosensitivity Via Inducing Cell Cycle Arrest and Apoptosis in Cervical Cancer Cells.

Inhibition of Aurora-A Results in Increased Cell Death in 3-Dimensional Culture Microenvironment, Reduced Migration and is Associated with Enhanced Radiosensitivity in Human Nasopharyngeal Carcinoma

Cancer esearch cular and Cellular Pathobiology Mitotic Kinase Aurora-A Induces Mammary l Migration and Breast Cancer Metastasis R ctivating the Cofilin-F-actin Pathway

Overexpression of Aurora-A Kinase Promotes Tumor Cell Proliferation and Inhibits Apoptosis in Esophageal Squamous Cell Carcinoma Cell Line.

Data from The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway

Inhibition of Aurora-A Promotes CD8+ T-Cell Infiltration by Mediating IL10 Production in Cancer Cells.

Inhibition of Mitotic Kinase Aurora Suppresses Akt-1 Activation and Induces Apoptotic Cell Death in All-Trans Retinoid Acid-Resistant Acute Promyelocytic Leukemia Cells

Aurora-B and HDAC Synergistically Regulate Survival and Proliferation of Lymphoma Cell Via AKT, Mtor and Notch Pathways.